These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8704742)

  • 21. [Tumors of the urinary bladder. Report from a Committee of the Danish Urological society from 1978].
    Ugeskr Laeger; 1982 Apr; 144(15):1063-74. PubMed ID: 7101558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Incidental inverted papilloma during the clinical follow-up of superficial transitional cell carcinoma in the urinary bladder].
    Sasamoto H; Matsumoto K; Matsushita K; Tsuboi T; Yamashita H; Satoh T; Iwamura M; Baba S; Mikami T
    Hinyokika Kiyo; 2008 Feb; 54(2):131-4. PubMed ID: 18323173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    Parekh DJ; Bochner BH; Dalbagni G
    J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis on the treatments of infiltrating tumors of the bladder].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):1143-57. PubMed ID: 12536939
    [No Abstract]   [Full Text] [Related]  

  • 25. Searching for novel therapeutics and targets: insights from clinical trials.
    Mitra AP; Cote RJ
    Urol Oncol; 2007; 25(4):341-3. PubMed ID: 17628305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management.
    Solsona E; Iborra I; Ricós JV; Dumont R; Casanova JL; Calabuig C
    Urology; 1997 Mar; 49(3):347-52. PubMed ID: 9123696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
    Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
    Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of bladder tumors at a county hospital--a proposal for a care program].
    Berge T; Hedenberg I
    Lakartidningen; 1980 Oct; 77(43):3877-80. PubMed ID: 7453368
    [No Abstract]   [Full Text] [Related]  

  • 31. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expectant treatment of superficial bladder tumors: preliminary results].
    Páez Borda A; de la Cal López MA; Llorente Abarca C; Acebal Lucia J; Herrero Payo A; Sánchez Sánchez E; Ruiz de la Roja JC; Berenguer Sánchez A
    Actas Urol Esp; 1995 Apr; 19(4):288-93. PubMed ID: 8815653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of therapy in different groups of risk for superficial bladder cancer].
    Startsev VIu; Gorelov SI; Pulin IL; Merkur'eva RD; Ogava I
    Vopr Onkol; 2006; 52(2):187-91. PubMed ID: 17195646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroendocrine differentiation of bladder tumors].
    Vincendeau S; de Lajarte-Thirouard AS; Bensalah K; Guillé F; Lobel B; Patard JJ
    Prog Urol; 2003 Jun; 13(3):375-84. PubMed ID: 12940189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical factors in the treatment of superficial and invasive bladder cancer.
    Herr HW
    Urol Clin North Am; 2005 May; 32(2):157-64. PubMed ID: 15862613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and therapy of superficial tumors of the urinary bladder].
    Babjuk M; Dvorácek J
    Cas Lek Cesk; 2002 Nov; 141(23):723-8. PubMed ID: 12650028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.